Hsbc Holdings PLC Has $126.22 Million Stake in Humana Inc. $HUM

Hsbc Holdings PLC reduced its position in Humana Inc. (NYSE:HUM - Free Report) by 2.7% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 318,091 shares of the insurance provider's stock after selling 8,933 shares during the period. Hsbc Holdings PLC owned approximately 0.26% of Humana worth $126,221,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. Revolve Wealth Partners LLC acquired a new position in shares of Humana during the fourth quarter valued at about $202,000. Woodline Partners LP raised its holdings in shares of Humana by 460.0% in the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider's stock worth $2,697,000 after acquiring an additional 8,372 shares during the last quarter. Sivia Capital Partners LLC lifted its position in Humana by 53.7% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider's stock valued at $316,000 after acquiring an additional 452 shares in the last quarter. Cresset Asset Management LLC lifted its position in Humana by 10.3% in the 2nd quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider's stock valued at $581,000 after acquiring an additional 222 shares in the last quarter. Finally, WINTON GROUP Ltd boosted its stake in Humana by 58.5% during the 2nd quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider's stock valued at $582,000 after purchasing an additional 879 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Stock Performance

NYSE HUM opened at $388.92 on Wednesday. The company's 50 day moving average is $383.88 and its 200-day moving average is $285.00. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The firm has a market cap of $46.70 billion, a P/E ratio of 36.79, a price-to-earnings-growth ratio of 2.20 and a beta of 0.72.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same period last year, the firm earned $6.27 EPS. Humana's revenue for the quarter was up 26.2% on a year-over-year basis. Sell-side analysts predict that Humana Inc. will post 9.12 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have commented on HUM. William Blair initiated coverage on Humana in a report on Wednesday, May 20th. They set an "outperform" rating for the company. Seaport Research Partners cut Humana to a "neutral" rating in a research report on Wednesday, May 20th. Mizuho upped their price target on Humana from $335.00 to $390.00 and gave the stock an "outperform" rating in a report on Monday, June 8th. Lake Street Capital assumed coverage on shares of Humana in a research note on Thursday, July 30th. They issued a "buy" rating for the company. Finally, Deutsche Bank Aktiengesellschaft began coverage on shares of Humana in a report on Thursday, July 30th. They set a "hold" rating for the company. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $403.91.

About Humana

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source